DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Lubenow N, Warkentin TE, Greinacher A. , et al.
Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990s.
Thromb Res 2006;
117 (05) 507-515
We do not assume any responsibility for the contents of the web pages of other providers.